HCR 22: urging the united states congress to pass H.r. 2687, also known as the end kidney deaths act.
- Session Year: 2025-2026
- House: House
- Latest Version Date: 2026-03-03
Current Status:
In Progress
(2026-04-10: Referred to EIG/HHS.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Final Decking
Enacted
What does this bill do?
This resolution urges Congress to pass H.R. 2687, the End Kidney Deaths Act, which would provide regulated, refundable tax credits to people who donate a kidney to someone they do not know. It seeks to boost living kidney donations to save lives, reduce health inequities, and lower long-term costs for people with kidney failure.
The summary is provided by generative AI which can make mistakes. For original language, please view the details in the table below.
urging the united states congress to pass H.r. 2687, also known as the end kidney deaths act.
|
HOUSE OF REPRESENTATIVES |
H.C.R. NO. |
22 |
|
THIRTY-THIRD LEGISLATURE, 2026 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
HOUSE CONCURRENT
RESOLUTION
urging the united states congress to pass H.r. 2687, also known as the end kidney deaths act.
WHEREAS, kidney disease and kidney failure are serious, life-threatening medical conditions that disproportionately impact people of color; and
WHEREAS, currently more than five thousand Hawaii residents rely on dialysis and hundreds die each year; and
WHEREAS, patients from rural and low-income communities are significantly more likely to die from kidney disease due to the deep inequities in access to timely and effective treatment; and
WHEREAS, of the nearly ninety-five thousand Americans nationwide who are waiting for a kidney transplant, several thousands die each year, despite kidney transplantation being a proven, life-saving therapy; and
WHEREAS, while dialysis can sustain a patient's life, it also significantly diminishes quality of life, shortens life expectancy, and imposes substantial physical, emotional, and financial burdens on patients and families; and
WHEREAS, the federal government spends approximately $50,000,000,000 annually on dialysis care, which represents nearly one percent of all federal spending; and
WHEREAS, kidney transplantation not only restores health and independence for patients but also reduces long-term public expenditures, with each transplant estimated to save approximately $500,000 compared to the lifetime cost of dialysis; and
WHEREAS, expanding access to kidney transplantation has the potential to save up to ten thousand lives each year and reduce federal health care spending by approximately $4,000,000,000 annually; and
WHEREAS, living donor kidney transplants are widely recognized as the gold standard of kidney care, offering better outcomes and longer graft survival than deceased donor transplants; and
WHEREAS, living kidney donation is already among the most tightly regulated medical procedures in the United States, with comprehensive medical, psychological, and ethical safeguards to protect donor safety and prevent coercion; and
WHEREAS, the number of living kidney donors has remained largely unchanged for more than twenty-five years, demonstrating that existing policies have failed to meet the growing need for donors; and
WHEREAS, H.R. 2687, also known as the End Kidney Deaths Act, was introduced on April 7, 2025, to the 119th Congress; and
WHEREAS, the End Kidney Deaths Act would allow for regulated, refundable tax credits for individuals who donate a kidney to a stranger; and
WHEREAS, providing tax credits for non-directed living donation recognizes the burdens of donation while preserving existing donor protections; and
WHEREAS, non-directed kidney donation can initiate transplant changes that save multiple lives from a single act of generosity; and
WHEREAS, the End Kidney Deaths Act is a bipartisan, evidence-based proposal that address human suffering and fiscal responsibility; now, therefore,
BE IT RESOLVED by the House of Representatives of the Thirty-third Legislature of the State of Hawaii, Regular Session of 2026, the Senate concurring, that this body urges the United States Congress to pass H.R. 2687, also known as the End Kidney Deaths Act; and
BE IT FURTHER RESOLVED that this body urges Hawaii's congressional delegation to support the End Kidney Deaths Act as a means of saving lives, reducing health inequities that affect rural and low-income communities, and improving the sustainability of the nation's health care system; and
BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the President of the United States, Speaker of the United States House of Representatives, President Pro Tempore of the United States Senate, and members of Hawaii's congressional delegation.
|
|
OFFERED BY: |
_____________________________ |
|
|
|
|
Kidney Disease; Kidney Donation; Tax Credits; End Kidney Deaths Act
|
Date
|
Status
|
|---|---|
| Apr 10, 2026 | Referred to EIG/HHS. |
| Apr 10, 2026 | Received from House (Hse. Com. No. 538). |
| Apr 9, 2026 | Transmitted to Senate. |
| Apr 9, 2026 | Adopted with none voting aye with reservations; none voting no (0) and Representative(s) Cochran excused (1). |
| Apr 9, 2026 | Reported from JHA (Stand. Com. Rep. No. 1880-26), recommending adoption. |
| Apr 7, 2026 | The committee on JHA recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 6 Ayes: Representative(s) Tarnas, Poepoe, Belatti, Takayama, Garcia, Shimizu; Ayes with reservations: none; Noes: none; and 4 Excused: Representative(s) Hashem, Kahaloa, Sayama, Cochran. |
| Apr 2, 2026 | Resolution scheduled to be heard by JHA on Tuesday, 04-07-26 2:00PM in conference room 325 VIA VIDEOCONFERENCE. |
| Apr 1, 2026 | Report adopted; referred to the committee(s) on JHA with none voting aye with reservations; none voting no (0) and none excused (0). |
| Apr 1, 2026 | Reported from HLT (Stand. Com. Rep. No. 1592-26), recommending referral to JHA. |
| Mar 25, 2026 | The committee on HLT recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 9 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Hartsfield, Marten, Olds, Takenouchi, Alcos, Garcia; Ayes with reservations: none; Noes: none; and Excused: none. |
| Mar 20, 2026 | Resolution scheduled to be heard by HLT on Wednesday, 03-25-26 9:30AM in conference room 329 VIA VIDEOCONFERENCE. |
| Mar 10, 2026 | Referred to HLT, JHA, referral sheet 15 |
| Mar 5, 2026 | Offered |
| Mar 3, 2026 | To be offered. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Apr 7, 2026 | The committee on JHA recommend that the measure be PASSED, UNAMENDED | House Standing Committee on Judiciary & Hawaiian Affairs |
Passed |
|
| Mar 25, 2026 | The committee on HLT recommend that the measure be PASSED, UNAMENDED | House Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Date
|
Testimony PDF
|
|---|---|
| Apr 7, 2026 | HCR22_TESTIMONY_JHA_04-07-26_.PDF |
| Mar 25, 2026 | HCR22_TESTIMONY_HLT-HSH_03-25-26_.PDF |
Discussed in Hearing
House Standing Committee on Judiciary & Hawaiian Affairs
House Standing Committee on Judiciary & Hawaiian Affairs
Bill Author
Bill Co-Author(s):